Purchase Order 12405B19P0254

This is a $5,820 firm-fixed price purchase order awarded by the National Institutes of Health (NIH) to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for monoclonal antibody production services. The contract is not set-aside and was awarded under the NIH's Acquisition Operations. Precision Antibody is a for-profit manufacturer of specialized biological materials and services, including custom antibody development, cell lines, and peptide synthesis, in support of biomedical...

This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), to Pacific Immunology, a USA-based biotech company located in Ramona, California. The contract is for the production of monospecific antibodies, with a ceiling value of $4,321.60 and an ultimate completion date of March 10, 2010. The contract does not utilize a set-aside designation. Pacific Immunology, the prime...

This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...

This firm fixed price purchase order was awarded by the National Institutes of Health National Cancer Institute to Genscript USA Inc. for $30,280. The contract is for the acquisition of recombinant antibody against mouse ErbB2 (HER2) domain IV via custom protein production services. Specifically, Genscript will immunize rabbits with the antigen protein, collect B cell clones to screen for binding to mouse HER2, collect supernatants from 20 antibody clones, and produce and purify the...

This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody). The contract is for the preparation of monoclonal antibodies against the MARCH1 protein, with a ceiling value of $16,900.00 and a performance period through July 31, 2025. A&G Pharmaceutical is a for-profit manufacturer of biological...

This firm-fixed price purchase order was awarded to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,951.40 award is for the delivery of custom antibody development services including monoclonal antibodies, cell lines, labeled antibodies, polyclonal antibodies, and peptide synthesis. These...

Pacific Immunology has been awarded a $19,813 purchase order contract by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide antibody production testing services in support of the agency's biomedical research efforts. The firm fixed price contract runs from September 2023 through September 2024 and will be performed in Ramona, California. No subcontractors or set aside designations were identified. This award...

This is a $23,086.75 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to A&G Pharmaceutical, Inc., doing business as Precision Antibody. Precision Antibody is a for-profit manufacturer of goods that provides custom antibody development services to support biomedical research. This contract is not set aside for small businesses. The award supports research efforts through the...

Genscript USA Inc. was awarded a $90,340 purchase order by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. Under the terms of the contract, Genscript will provide bulk antibody production services in support of the CDC's CVV (Comparative Vaccine Vector) program. Performance will take place at Genscript's facility in Chamblee, Georgia over the course of one year, from September 2022 through September 2023. The contract has a firm fixed price and no set-aside...

Pacific Immunology was awarded a $3,119.50 firm fixed price purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide antibody production services for rabbits. Specifically, the contract calls for Package #1: Antibody Production (Rabbits) for AB1001. The place of performance will be Pacific Immunology's facility in Ramona, California. The period of performance is one month, from June 25, 2013 through July 26, 2013. No set-aside...